Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. HeraMED Limited
  6. News
  7. Summary
    HMD   AU0000028367

HERAMED LIMITED

(HMD)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

HeraMED Limited Announces Sheba Medical Centre, Initiates Pilot to Test Both the HeraBEAT Device and HeraCARE Platform

02/07/2021 | 05:05pm EDT

HeraMED Limited (HeraMED or the Company) announced that Sheba Medical Centre, Israel's largest hospital has initiated a pilot to test both the HeraBEAT device and HeraCARE platform. The pilot will be undertaken at the Sheba Medical Centre at Tel-Hashomer, a university-affiliated tertiary referral hospital that serves as Israel's national medical centre in many fields. The pilot involves several defined stages. During the first stage, which begins immediately, Sheba will use the HeraBEAT smart pregnancy monitors in operational mode to enable telehealth-based services in their dedicated pregnancy COVID-19 unit. Pregnant women who are admitted to the Covid-19 unit require continuous monitoring. The HeraBEAT monitors will enable real-time foetal and maternal heart rate monitoring and analysis by Sheba's midwives and obstetricians, limiting the amount of physical interaction to potentially reduce the risk of COVID-19 exposure and spread. The second stage of the pilot will involve a much wider study providing additional use cases beyond COVID-19 such as high-risk pregnancies and post-term in which constant and real-time remote pregnancy monitoring is necessary. This stage holds significant potential to include a wide audience of pregnant women. This pilot will further include both in-hospital as well as in-home used-cases, and it is a part of Sheba BEYOND's vision to become a leader in virtual care and home admission services. During the first stage of the pilot, each party will cover its own costs; HeraMED will work closely with the professional team at Sheba to ensure the technology is successfully integrated into their workflows and IT infrastructure. This work is expected to underpin an efficient adoption for the anticipated full-scale, commercial deployment.


ę S&P Capital IQ 2021
All news about HERAMED LIMITED
09/12HeraMED Limited Provides Positive Interim Results US Paid Pilot & 2nd Site Confirmed
CI
08/27HeraMED Limited Reports Earnings Results for the Half Year Ended June 30, 2021
CI
08/13HERAMED : Begins Pilot Program for Maternal Care Platform
MT
07/18HERAMED : Obstetrix Medical Signs Deal for Integration of Maternity Care Platform HeraCARE..
MT
07/18HeraMED Limited Announces Change of Registered Office
CI
07/18HeraMED Limited Announces Pilot Agreement with Obstetrix Medical Group
CI
05/13HERAMED : Enters Pilot Deal With US Clinical Services Provider
MT
05/12HeraMED Limited Announces Pilot Agreement with Obstetrix Medical Group
CI
04/22HERAMED : Signs Deal with Joondalup Health Campus for HeraCARE Platform; Shares Gain 4%
MT
04/21HeraMED Limited Announces Signed an Agreement with Joondalup Health Campus
CI
More news
Financials (USD)
Sales 2020 0,04 M - -
Net income 2020 -3,36 M - -
Net cash 2020 1,75 M - -
P/E ratio 2020 -4,12x
Yield 2020 -
Capitalization 27,0 M 27,0 M -
EV / Sales 2019 67,0x
EV / Sales 2020 277x
Nbr of Employees -
Free-Float 61,5%
Chart HERAMED LIMITED
Duration : Period :
HeraMED Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HERAMED LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Managers and Directors
David Groberman Chief Executive Officer, Director & MD
Sivan Sadan Chief Financial Officer
Ronald Peter Weinberger Non-Executive Chairman
Josef Tovbin Chief Medical Officer
Michael Nenner Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
HERAMED LIMITED90.91%27
THERMO FISHER SCIENTIFIC30.58%239 899
DANAHER CORPORATION46.32%231 660
INTUITIVE SURGICAL, INC.27.53%124 147
SIEMENS HEALTHINEERS AG42.12%78 408
EDWARDS LIFESCIENCES CORPORATION32.65%74 843